**Chapter 8**

*Thymus*

1997;**76**(1):21-29

2015;**16**(2):177-186

2004. pp. 145-247

neoplasia type 1. Medicine (Baltimore).

IVA thymoma. The Annals of Thoracic

Surgery. 2006;**82**(4):1234-1239

[63] Thomas A, Rajan A, Berman A, Giaccone G. Multiorgan autoimmune manifestations associated with thymoma. Journal of Thoracic Oncology. 2015;**10**(2):e5-e7

[64] Thomas A, Rajan A, Beran A, Tomita Y, Brzezniak C, Lee MJ, et al. Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: An open-label phase 2 trial. The Lancet Oncology.

[65] Tomiyoma N, Johkoh T, Mihara N, Honda O, Kozuka T, Koyama M, et al. Using the World Health Organization Classification of thymic epithelial neoplasms to describe CT findings. AJR. American Journal of Roentgenology. 2002;**179**(4):881-886

[66] Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. Pathology & Genetics Tumours of the Lung, Pleura, Thymus and Heart. lyon: IARC Press;

[67] Wei Y, Gu Z, Shen Y, Fu J, Tan L, Zhang P, et al. Preoperative induction therapy for locally advanced thymic tumors: A retrospective analysis using the ChART database. Journal of Thoracic Disease. 2016;**8**(4):665-672

[68] Willcox N, Leite MI, Kadota Y, Jones M, Meager A, Subrahmanyam P, et al. Autoimmunizing mechanisms in thymoma and thymus. Annals of the New York Academy of Sciences.

resections for thymic malignancies. Journal of Thoracic Oncology. 2010;**10**(supp 4):S344-S347

[70] Wright CD. Pleuropneumonectomy for the treatment of Masaoka stage

2008;**1132**(1):163-172

[69] Wright CD. Extended

**90**
